Retour

ERYTECH PHARMA (EPA:ERYP) ERYTECH Highlights 2021 Milestones and Provides Update on Cash Position

Directive transparence : information réglementée

25/01/2021 22:30

19/04/2021 07:30

ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator...

07/04/2021 22:30

ERYTECH to Participate in Upcoming Virtual Investor Conferences in April

09/03/2021 22:30

ERYTECH Announces Filing of 2020 Universal Registration Document and 2020...

08/03/2021 22:30

ERYTECH Provides Business Update and Reports Financial Results for the...

04/03/2021 22:30

ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and...

24/02/2021 22:30

ERYTECH to Participate in Upcoming Virtual Investor Conferences in March

10/02/2021 22:30

ERYTECH to Present at the 2021 BIO CEO & Investor Conference

04/02/2021 19:00

Monthly information related to total number of voting rights and shares...

25/01/2021 22:30

ERYTECH Highlights 2021 Milestones and Provides Update on Cash Position

14/01/2021 22:30

ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator...

Voir tous les communiqués de ERYTECH PHARMA